Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Nicola Abate, Hanaa S. Sallam, Manfredi Rizzo, Dragana Nikolic, Milan Obradovic, Predrag Bjelogrlic and Esma R. Isenovic
Affiliation: Institute Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, P.O.Box 522, 11000 Belgrade, Serbia.
Keywords: Resistin, type 2 diabetes, cardiovascular diseases, metabolic syndrome.
Resistin is an adipocyte- and monocyte-derived cytokine which has been implicated in the modulation of insulin action, energy,
glucose and lipid homeostasis. Resistin has been associated with insulin resistance and many of its known complications. As a molecular
link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in
the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic
syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular diseases (CVD). In this review, we highlighted the role of resistin,
as an inflammatory cytokine, in the development of CVD, T2DM and the MetS.
Rights & PermissionsPrintExport